A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies (Q82123128)
Jump to navigation
Jump to search
scientific article published on 19 October 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies |
scientific article published on 19 October 2011 |
Statements
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies (English)
H-T Arkenau
R Plummer
L R Molife
D Olmos
T A Yap
M Squires
S Lewis
V Lock
M Yule
J Lyons
H Calvert